1.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: P100, NCT01185470
|
|
2.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 10-1056, NCT01269918
|
|
3.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: Any Age Sponsor: Pharmaceutical / Industry Protocol IDs: CDX-353-002, NCT01660633
|
|
4.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: OmegaDVS, NCT01803711
|
|
5.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other, Pharmaceutical / Industry Protocol IDs: SCCC-022006-010, 022006-010, PFIZER-SCCC-022006-010, NCT00631891
|
|
6.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08D.380, 2007-32, NCT00806611
|
|
7.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000675520, NCCTG-N09C6, N09C6, NCT01156142
|
|
8.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: VAR0054, SU-02032010-4882, NCT01067144
|
|
9.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: V212-011, NCT01254630
|
|
10.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GWCA0958, 2009-016064-36, NCT01262651
|
|
11.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GWCA0999, 2009-016529-32, NCT01337089
|
|
12.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-034, NCT01355926
|
|
13.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GWCA0962, 2009-016065-29, NCT01361607
|
|
14.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011-0146, NCT01438476
|
|
15.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: Postmenopausal Sponsor: NCI, Other Protocol IDs: CDR0000725249, SWOG-S1200, R01AT000636-01, U10CA037429, S1200, NCT01535066
|
|
16.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: OHSU IRB 7630, NCT01539317
|
|
17.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-001687, NCT01591746
|
|
18.
|
Phase: Phase III Type: Supportive care Status: Active Age: 6 to 19 Sponsor: Pharmaceutical / Industry Protocol IDs: OTR3001, 2010-020471-23, NCT01192295
|
|
19.
|
Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: NYM-354, NCT00374751
|
|
20.
|
Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 090039, 09-D-0039, NCT00804154
|
|
21.
|
Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 603EUSA03, NCT00901732
|
|
22.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: 2009-0517, NCT01219673
|
|
23.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 4P-09-9, NCI-2009-01418, NCT01240629
|
|
24.
|
Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 40 to 80 Sponsor: Other Protocol IDs: AAAI5060, NCT01565512
|
|
25.
|
Phase: Phase II Type: Supportive care Status: Active Age: 2 to 18 Sponsor: Other Protocol IDs: MCW-HRRC-28600, MCW-CHW-0070, NCI-V02-1699, NCT00036712
|